Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jeffrey Swigris

Concepts (372)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
697
11.630
Why?
Lung Diseases, Interstitial
63
2026
677
10.640
Why?
Dyspnea
29
2026
251
6.520
Why?
Quality of Life
48
2026
3187
6.010
Why?
Pulmonary Fibrosis
26
2025
395
5.430
Why?
Cough
10
2024
123
3.520
Why?
Oxygen Inhalation Therapy
13
2021
189
3.250
Why?
Vital Capacity
34
2026
293
3.030
Why?
Surveys and Questionnaires
39
2026
6050
2.940
Why?
Alveolitis, Extrinsic Allergic
7
2026
96
2.730
Why?
Connective Tissue Diseases
13
2019
85
2.240
Why?
Arthritis, Rheumatoid
13
2026
1184
1.810
Why?
Lymphangioleiomyomatosis
6
2024
37
1.700
Why?
Pyridones
12
2023
210
1.610
Why?
Patient Reported Outcome Measures
7
2024
502
1.480
Why?
Severity of Illness Index
21
2026
2910
1.470
Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
344
1.450
Why?
Patient Outcome Assessment
3
2021
128
1.380
Why?
Sarcoidosis
5
2021
164
1.330
Why?
Indoles
6
2024
509
1.330
Why?
Humans
168
2026
145625
1.280
Why?
Aged
71
2026
26251
1.250
Why?
Middle Aged
83
2026
36359
1.220
Why?
Pulmonary Medicine
3
2022
78
1.190
Why?
Lung
21
2024
4119
1.190
Why?
Psychometrics
11
2026
708
1.170
Why?
Fatigue
9
2024
362
1.140
Why?
Walking
7
2013
544
1.080
Why?
Respiratory Function Tests
19
2025
543
1.070
Why?
Oxygen
7
2023
996
0.980
Why?
Male
92
2026
73014
0.950
Why?
Patients
3
2018
183
0.950
Why?
Reproducibility of Results
19
2026
3396
0.950
Why?
Tomography, X-Ray Computed
20
2025
2766
0.940
Why?
Hypertension, Pulmonary
6
2023
1957
0.920
Why?
Female
95
2026
79080
0.920
Why?
Health Care Costs
3
2018
418
0.900
Why?
Exercise Test
9
2024
634
0.900
Why?
Research Design
5
2016
1139
0.890
Why?
Health Status Indicators
4
2014
166
0.890
Why?
Patient-Centered Care
2
2021
551
0.850
Why?
Activities of Daily Living
6
2022
438
0.840
Why?
Disease Progression
20
2025
2857
0.830
Why?
Exercise Tolerance
4
2020
288
0.780
Why?
Mycophenolic Acid
4
2016
117
0.730
Why?
Forced Expiratory Volume
12
2023
451
0.710
Why?
Idiopathic Interstitial Pneumonias
7
2026
44
0.680
Why?
Internet
2
2016
656
0.680
Why?
Organizational Objectives
1
2021
67
0.670
Why?
Autoimmune Diseases
5
2026
466
0.660
Why?
Nursing Research
1
2021
49
0.660
Why?
Patient Satisfaction
3
2021
698
0.660
Why?
Caregivers
4
2019
1079
0.640
Why?
Pulmonary Emphysema
2
2024
276
0.620
Why?
Lactic Acid
1
2022
295
0.620
Why?
Rhinitis, Allergic
1
2020
41
0.600
Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.590
Why?
Symptom Assessment
1
2020
137
0.590
Why?
Chronic Disease
5
2022
1824
0.590
Why?
Prognosis
17
2026
4331
0.580
Why?
Pulmonary Disease, Chronic Obstructive
4
2022
926
0.570
Why?
Fatty Acids
1
2022
460
0.550
Why?
Emphysema
1
2018
100
0.520
Why?
Patient Education as Topic
3
2019
769
0.500
Why?
Particulate Matter
1
2020
328
0.500
Why?
Needs Assessment
2
2019
403
0.490
Why?
Longitudinal Studies
9
2020
3005
0.480
Why?
Lung Diseases
3
2015
787
0.480
Why?
Pulmonary Diffusing Capacity
7
2019
78
0.470
Why?
Aged, 80 and over
19
2021
8351
0.470
Why?
Heart Rate
2
2011
844
0.470
Why?
Immunosuppressive Agents
4
2016
824
0.460
Why?
Lung Transplantation
1
2019
326
0.450
Why?
Air Pollutants
1
2020
406
0.450
Why?
Qualitative Research
4
2017
1720
0.450
Why?
Information Seeking Behavior
1
2016
39
0.450
Why?
United States
25
2024
16041
0.450
Why?
Treatment Outcome
20
2023
11744
0.450
Why?
Myositis
4
2025
57
0.450
Why?
Gastroesophageal Reflux
2
2021
232
0.440
Why?
Exercise
4
2022
2206
0.430
Why?
Adult
39
2024
40821
0.430
Why?
Narration
1
2016
82
0.420
Why?
Double-Blind Method
10
2024
2064
0.420
Why?
Ambulatory Care
2
2018
627
0.420
Why?
Mental Health
2
2020
771
0.410
Why?
Kaplan-Meier Estimate
8
2018
959
0.410
Why?
Autoantibodies
6
2023
1498
0.400
Why?
Retrospective Studies
27
2025
17291
0.400
Why?
Autoimmunity
2
2019
924
0.400
Why?
Telemedicine
1
2023
956
0.400
Why?
Antibodies, Monoclonal
1
2021
1511
0.390
Why?
Biomedical Research
2
2018
724
0.390
Why?
Antitussive Agents
1
2013
7
0.380
Why?
Social Media
1
2016
158
0.380
Why?
Bronchiolitis Obliterans
1
2013
59
0.380
Why?
Thalidomide
1
2013
43
0.370
Why?
Lung Neoplasms
4
2024
2674
0.370
Why?
Social Support
2
2019
644
0.360
Why?
Motivation
1
2017
601
0.360
Why?
Physicians
2
2019
954
0.360
Why?
Survival Rate
7
2019
2078
0.360
Why?
Bronchial Diseases
1
2012
38
0.360
Why?
Prospective Studies
10
2026
8087
0.350
Why?
Patient Participation
1
2015
454
0.340
Why?
Follow-Up Studies
9
2018
5397
0.340
Why?
Quality Indicators, Health Care
1
2014
340
0.330
Why?
Oxygen Consumption
3
2022
719
0.330
Why?
Scleroderma, Systemic
4
2019
123
0.330
Why?
Health Knowledge, Attitudes, Practice
2
2018
1403
0.320
Why?
Multivariate Analysis
5
2017
1531
0.320
Why?
Health Status
5
2019
822
0.310
Why?
Peptides, Cyclic
1
2012
276
0.310
Why?
Motor Activity
1
2014
701
0.300
Why?
Asthma
2
2020
1800
0.300
Why?
Endothelins
1
2010
61
0.300
Why?
Protein Kinase Inhibitors
3
2021
982
0.300
Why?
Hospitalization
3
2017
2468
0.300
Why?
Cause of Death
6
2019
455
0.290
Why?
Diagnosis, Differential
7
2019
1500
0.290
Why?
Pulmonologists
2
2019
14
0.280
Why?
Pulmonary Embolism
1
2011
245
0.280
Why?
Endothelin-1
1
2010
177
0.280
Why?
TRPP Cation Channels
1
2009
76
0.280
Why?
Proportional Hazards Models
4
2019
1318
0.270
Why?
Amino Acyl-tRNA Synthetases
3
2016
32
0.270
Why?
Cohort Studies
8
2025
6045
0.270
Why?
Registries
4
2025
2382
0.270
Why?
Polycystic Kidney Diseases
1
2009
82
0.260
Why?
Randomized Controlled Trials as Topic
6
2021
1754
0.260
Why?
Sleep Apnea, Obstructive
1
2012
300
0.260
Why?
Sirolimus
2
2023
282
0.250
Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.240
Why?
Biopsy
7
2016
1073
0.240
Why?
Bronchoalveolar Lavage Fluid
2
2025
641
0.240
Why?
Sex Distribution
3
2012
379
0.240
Why?
Tumor Suppressor Proteins
1
2009
314
0.240
Why?
Home Care Services
2
2020
290
0.230
Why?
Mortality
4
2019
375
0.230
Why?
Prevalence
5
2018
2852
0.230
Why?
Exercise Therapy
3
2024
486
0.230
Why?
Cost of Illness
3
2018
322
0.230
Why?
Palliative Care
3
2019
1032
0.230
Why?
Patient Advocacy
2
2024
73
0.230
Why?
Lupus Erythematosus, Systemic
1
2008
240
0.220
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
121
0.220
Why?
Quality Improvement
1
2014
1325
0.210
Why?
Fibrosis
2
2024
568
0.200
Why?
Minimal Clinically Important Difference
2
2021
35
0.200
Why?
Thrombosis
1
2008
397
0.200
Why?
Age Distribution
3
2019
395
0.190
Why?
Time Factors
7
2019
7079
0.190
Why?
Databases, Factual
3
2019
1481
0.190
Why?
Evidence-Based Medicine
2
2020
727
0.190
Why?
Delphi Technique
1
2024
347
0.180
Why?
Respiratory Therapy
2
2019
25
0.180
Why?
Sex Factors
6
2019
2101
0.180
Why?
Environmental Exposure
2
2020
578
0.170
Why?
Receptors, Lysophosphatidic Acid
1
2021
40
0.170
Why?
Risk Factors
9
2026
10840
0.170
Why?
Patient Care Management
1
2021
54
0.160
Why?
Incidence
3
2018
2910
0.160
Why?
Analysis of Variance
3
2015
1293
0.160
Why?
Linear Models
3
2019
847
0.160
Why?
Survival Analysis
3
2017
1372
0.150
Why?
Interleukin-13
1
2021
149
0.150
Why?
Logistic Models
4
2019
2112
0.150
Why?
Antibodies, Antinuclear
4
2016
60
0.150
Why?
Pain Measurement
1
2022
567
0.150
Why?
Walk Test
2
2017
82
0.150
Why?
Focus Groups
3
2016
587
0.150
Why?
Sensitivity and Specificity
3
2015
1992
0.150
Why?
Chi-Square Distribution
2
2011
511
0.140
Why?
General Practitioners
1
2019
26
0.140
Why?
Allied Health Personnel
1
2019
54
0.140
Why?
Immunoglobulin A
1
2019
205
0.140
Why?
Insurance Claim Review
1
2018
85
0.140
Why?
Terminal Care
2
2019
284
0.130
Why?
Lipid Metabolism
1
2022
533
0.130
Why?
Oxidation-Reduction
1
2022
1075
0.130
Why?
Accelerometry
2
2019
123
0.130
Why?
Anxiety
3
2019
1118
0.130
Why?
Attitude to Health
2
2014
419
0.130
Why?
Physician Assistants
1
2019
101
0.120
Why?
Weight-Bearing
1
2018
186
0.120
Why?
Cellular Senescence
1
2019
225
0.120
Why?
Allergens
1
2020
390
0.120
Why?
Cross-Sectional Studies
4
2019
5875
0.120
Why?
Inflammation
2
2025
2915
0.120
Why?
Germany
1
2017
139
0.120
Why?
Nurse Practitioners
1
2019
141
0.120
Why?
Nurses
1
2019
171
0.120
Why?
Common Variable Immunodeficiency
1
2016
26
0.120
Why?
Perception
1
2019
372
0.120
Why?
Host-Pathogen Interactions
1
2019
366
0.120
Why?
Sulfonamides
2
2010
592
0.120
Why?
Antihypertensive Agents
2
2010
519
0.120
Why?
Tidal Volume
1
2016
108
0.120
Why?
Granuloma
1
2016
96
0.120
Why?
Cyclophosphamide
1
2016
275
0.110
Why?
Medicare
2
2018
907
0.110
Why?
Muscle Strength
2
2015
332
0.110
Why?
Clinical Trials as Topic
3
2024
1062
0.110
Why?
Health Policy
1
2018
399
0.110
Why?
Nitric Oxide
1
2020
883
0.110
Why?
Physical Conditioning, Human
1
2015
38
0.110
Why?
Rituximab
1
2016
208
0.110
Why?
Neuroendocrine Cells
1
2015
34
0.110
Why?
Geographic Information Systems
1
2014
45
0.110
Why?
Case-Control Studies
4
2019
3633
0.100
Why?
Enzyme Inhibitors
2
2016
820
0.100
Why?
Recovery of Function
1
2018
721
0.100
Why?
Interviews as Topic
2
2016
926
0.100
Why?
Controlled Clinical Trials as Topic
1
2013
26
0.100
Why?
Societies, Medical
5
2020
901
0.100
Why?
Sarcoidosis, Pulmonary
1
2015
100
0.100
Why?
Sildenafil Citrate
1
2013
60
0.100
Why?
Information Dissemination
1
2016
224
0.100
Why?
Carbon Monoxide
3
2019
82
0.100
Why?
Antifibrinolytic Agents
1
2014
68
0.100
Why?
Sulfones
1
2013
127
0.100
Why?
Endpoint Determination
1
2013
84
0.090
Why?
Smoking
3
2019
1478
0.090
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
43
0.090
Why?
Phenotype
2
2018
3186
0.090
Why?
Predictive Value of Tests
3
2024
2097
0.090
Why?
Purines
1
2013
188
0.090
Why?
Practice Guidelines as Topic
1
2020
1581
0.090
Why?
Patient Dropouts
1
2013
65
0.090
Why?
Self Report
2
2019
869
0.090
Why?
Antibiotics, Antineoplastic
1
2013
140
0.090
Why?
Health Care Surveys
1
2014
538
0.090
Why?
Pulmonary Gas Exchange
1
2012
117
0.090
Why?
Histocompatibility Antigens Class II
1
2013
365
0.090
Why?
Occupational Exposure
1
2016
356
0.090
Why?
Vasodilator Agents
1
2013
326
0.090
Why?
Adaptation, Psychological
1
2017
718
0.090
Why?
Consensus
1
2013
465
0.090
Why?
Delivery of Health Care
1
2018
942
0.090
Why?
Dust
1
2012
92
0.090
Why?
Minnesota
1
2012
167
0.090
Why?
Piperazines
1
2013
367
0.080
Why?
United Kingdom
1
2012
376
0.080
Why?
Hydrogen-Ion Concentration
1
2012
533
0.080
Why?
Fear
1
2014
371
0.080
Why?
Epidemiologic Methods
1
2010
91
0.080
Why?
Young Adult
5
2017
14240
0.080
Why?
Anti-Infective Agents
1
2013
234
0.080
Why?
Health Surveys
1
2012
511
0.080
Why?
Clinical Competence
1
2019
1261
0.080
Why?
Sickness Impact Profile
2
2009
67
0.070
Why?
Salivary Glands, Minor
1
2009
9
0.070
Why?
Pilot Projects
2
2015
1878
0.070
Why?
Sjogren's Syndrome
1
2009
31
0.070
Why?
Hyperplasia
2
2015
164
0.070
Why?
International Cooperation
3
2015
192
0.070
Why?
Risk
1
2011
917
0.070
Why?
Scleroderma, Limited
1
2008
5
0.070
Why?
Europe
3
2015
420
0.070
Why?
Oximetry
1
2009
124
0.070
Why?
Poisson Distribution
3
2016
77
0.070
Why?
Radiography
2
2016
856
0.060
Why?
Cardiac Catheterization
1
2011
569
0.060
Why?
Wound Healing
1
2010
348
0.060
Why?
Comorbidity
2
2017
1652
0.060
Why?
Mass Screening
2
2026
1300
0.060
Why?
Sleep Wake Disorders
1
2011
314
0.060
Why?
Pericardium
1
2007
59
0.060
Why?
Models, Statistical
1
2011
667
0.060
Why?
Depression
2
2019
1566
0.060
Why?
Clinical Trials, Phase III as Topic
2
2016
116
0.060
Why?
Seasons
1
2008
535
0.060
Why?
Medical Records
1
2006
190
0.060
Why?
Regression Analysis
3
2016
994
0.060
Why?
Singapore
1
2024
27
0.050
Why?
California
1
2005
473
0.050
Why?
Echocardiography
1
2007
645
0.050
Why?
Bronchoscopy
1
2025
227
0.050
Why?
Dose-Response Relationship, Drug
2
2020
2018
0.050
Why?
Acute Disease
1
2006
1033
0.050
Why?
Data Interpretation, Statistical
2
2018
365
0.050
Why?
National Institutes of Health (U.S.)
1
2024
147
0.050
Why?
ROC Curve
1
2025
613
0.050
Why?
Terminology as Topic
1
2005
253
0.050
Why?
Lymphoid Tissue
1
2002
82
0.040
Why?
Rheumatologists
1
2022
15
0.040
Why?
Whole Genome Sequencing
1
2023
183
0.040
Why?
Exome
1
2023
232
0.040
Why?
Clinical Trials, Phase II as Topic
1
2021
74
0.040
Why?
Age Factors
3
2019
3321
0.040
Why?
Lysophospholipids
1
2021
80
0.040
Why?
Patient Care
1
2022
120
0.040
Why?
Patient Selection
1
2005
720
0.040
Why?
Telomere
1
2024
300
0.040
Why?
Attitude
1
2022
253
0.040
Why?
Total Lung Capacity
1
2019
29
0.040
Why?
Genomics
1
2025
851
0.040
Why?
Occupations
1
2019
50
0.040
Why?
Pulmonary Surfactant-Associated Protein A
1
2019
30
0.040
Why?
Adolescent
3
2017
22451
0.040
Why?
Pulmonary Surfactant-Associated Protein C
1
2019
45
0.040
Why?
GTPase-Activating Proteins
1
2019
81
0.040
Why?
Disease Models, Animal
1
2010
4565
0.040
Why?
Blood Gas Analysis
1
2019
80
0.040
Why?
Exoribonucleases
1
2019
48
0.030
Why?
ATP-Binding Cassette Transporters
1
2019
115
0.030
Why?
Administration, Inhalation
1
2020
567
0.030
Why?
Education
1
2018
102
0.030
Why?
DNA Helicases
1
2019
138
0.030
Why?
Telomere-Binding Proteins
1
2019
121
0.030
Why?
Watchful Waiting
1
2018
90
0.030
Why?
Administrative Claims, Healthcare
1
2017
28
0.030
Why?
Forecasting
1
2019
386
0.030
Why?
Physical Endurance
1
2019
278
0.030
Why?
Telomerase
1
2019
252
0.030
Why?
Mucin-5B
1
2019
234
0.030
Why?
Hypersplenism
1
2016
9
0.030
Why?
Spirometry
1
2017
234
0.030
Why?
Leukopenia
1
2016
33
0.030
Why?
Sequence Analysis, DNA
1
2019
771
0.030
Why?
Banking, Personal
1
2016
2
0.030
Why?
Algorithms
1
2024
1843
0.030
Why?
Rheumatoid Factor
1
2017
177
0.030
Why?
Health Care Sector
1
2016
25
0.030
Why?
Creatine Kinase
1
2016
70
0.030
Why?
Death Certificates
1
2016
32
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2019
538
0.030
Why?
Social Participation
1
2016
27
0.030
Why?
Arthritis
1
2016
97
0.030
Why?
Biomarkers
2
2019
4329
0.030
Why?
Health Services Needs and Demand
1
2017
283
0.030
Why?
Commerce
1
2016
80
0.030
Why?
International Classification of Diseases
1
2016
142
0.030
Why?
Multiple Pulmonary Nodules
1
2015
23
0.030
Why?
Metals
1
2016
137
0.030
Why?
Anthropometry
1
2015
203
0.030
Why?
Promoter Regions, Genetic
1
2019
1236
0.030
Why?
Physical Examination
1
2016
236
0.030
Why?
Pandemics
1
2023
1700
0.030
Why?
Genetic Variation
1
2019
992
0.030
Why?
Disease-Free Survival
1
2016
777
0.030
Why?
Alberta
1
2013
25
0.030
Why?
Bronchiolitis
1
2015
87
0.020
Why?
Mortality, Premature
1
2013
14
0.020
Why?
Adrenal Cortex Hormones
1
2016
483
0.020
Why?
Teaching
1
2016
243
0.020
Why?
Odds Ratio
1
2016
1070
0.020
Why?
Counseling
1
2016
403
0.020
Why?
Drug Therapy, Combination
1
2016
1034
0.020
Why?
RNA
1
2019
925
0.020
Why?
Congresses as Topic
1
2013
226
0.020
Why?
Genome-Wide Association Study
1
2019
1526
0.020
Why?
Administration, Oral
1
2014
867
0.020
Why?
Antigens, Human Platelet
1
2011
10
0.020
Why?
Latin America
1
2011
96
0.020
Why?
Japan
1
2011
149
0.020
Why?
Genetic Predisposition to Disease
1
2019
2455
0.020
Why?
Alanine-tRNA Ligase
1
2009
4
0.020
Why?
Threonine-tRNA Ligase
1
2009
5
0.020
Why?
Psychiatric Status Rating Scales
1
2011
512
0.020
Why?
DNA Topoisomerases, Type I
1
2008
15
0.020
Why?
Syndrome
1
2009
377
0.020
Why?
Cell Proliferation
1
2015
2497
0.020
Why?
Animals
1
2010
38030
0.020
Why?
Lymphocytes
1
2009
379
0.020
Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
Why?
Body Mass Index
1
2015
2446
0.010
Why?
Risk Assessment
1
2015
3678
0.010
Why?
Muscle, Skeletal
1
2015
1795
0.010
Why?
Nuclear Proteins
1
2008
739
0.010
Why?
Child
1
2002
22638
0.010
Why?
Pneumonia
1
2008
633
0.010
Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)